ESAB Corp·4

May 12, 4:47 PM ET

Teirlinck Didier P 4

4 · ESAB Corp · Filed May 12, 2026

Research Summary

AI-generated summary of this filing

Updated

ESAB (ESAB) Director Didier Teirlinck Receives 3,460-Unit Award

What Happened

  • Didier P. Teirlinck, a director of ESAB Corp (ESAB), received three awards on May 8, 2026 totaling 3,460 derivative units: 2,647 units, 407 units and 406 units. All were reported at $0.00 (awarded/issued), i.e., no cash changed hands. Footnotes indicate the package includes stock options that vested and became exercisable on the grant date, deferred stock units (DSUs), and restricted stock units (RSUs).

Key Details

  • Transaction date: May 8, 2026; Form 4 filed May 12, 2026.
  • Award amounts and reported prices: 2,647 @ $0.00; 407 @ $0.00; 406 @ $0.00 (total 3,460 units; total reported cash value $0).
  • Shares owned after the transaction: not disclosed in the provided excerpt of the filing.
  • Relevant footnotes: (F1) stock options vested and became exercisable on grant date; (F2/F3) DSUs represent contingent rights to one share and vest June 1, 2027, to be settled in stock after the director’s separation; (F4/F5) RSUs represent contingent rights to one share and vest in a single installment on June 1, 2027.
  • Timeliness: transaction date and filing date are shown; timeliness status (e.g., late filing flag) was not specified in the provided data.

Context

  • These were grants/awards (derivative awards), not open-market purchases or sales. The largest component includes stock options that, per the filing, vested and became exercisable immediately — exercising them would be a separate taxable/filing event. DSUs and RSUs are contingent rights to receive shares at vesting or settlement and are commonly used for director compensation. As always, awards reflect compensation arrangements and should not be read as a direct buy/sell signal.

Insider Transaction Report

Form 4
Period: 2026-05-08
Transactions
  • Award

    Stock Option (right to buy)

    [F1]
    2026-05-08+2,6472,647 total
    Exercise: $100.94From: 2026-05-08Exp: 2033-05-07Common stock, par value $0.001 (2,647 underlying)
  • Award

    Deferred Stock Units

    [F2][F3]
    2026-05-08+407407 total
    Common stock, par value $0.001 (407 underlying)
  • Award

    Restricted Stock Units

    [F4][F5]
    2026-05-08+406406 total
    From: 2027-06-01Exp: 2027-06-01Common stock, par value $0.001 (406 underlying)
Footnotes (5)
  • [F1]These stock options vested and became exercisable on the grant date.
  • [F2]Each deferred stock unit represents a contingent right to receive one share of ESAB common stock.
  • [F3]These deferred stock units vest in a single installment on June 1, 2027. Once vested, the units will be settled in ESAB common stock after the director's separation from the Company.
  • [F4]Each restricted stock unit represents a contingent right to receive one share of ESAB common stock.
  • [F5]These restricted stock units vest in a single installment on June 1, 2027.
Signature
/s/ Curtis E. Jewell, Attorney-in-Fact|2026-05-12

Documents

1 file
  • 4
    wk-form4_1778618831.xmlPrimary

    FORM 4